Start for free
Start for free
WM

Wheatley MedTech Partners

Description

Wheatley MedTech Partners is a venture capital fund based in New York, United States.

Investor Profile

Wheatley MedTech Partners has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Ediscovery
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wheatley MedTech Partners frequently co-invest with?

NIBC Bank N.V.
NIBC Bank N.V.
Europe, Zuid-Holland, The Netherlands, The Hague
Co-Investments: 1
Swiss Life Private Equity Partners
Swiss Life Private Equity Partners
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
DV
Durand Venture Associates
North America, New York, United States, New York
Co-Investments: 1
Bioventures Investors
Bioventures Investors
North America, Massachusetts, United States, Wellesley
Co-Investments: 1
Advent International
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
Oxford Bioscience Partners
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Wheatley Partners
Wheatley Partners
North America, New York, United States, Great Neck
Co-Investments: 1
Techno Venture Management
Techno Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Yasuda Enterprise Development
Yasuda Enterprise Development
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Wheatley MedTech Partners?

Oligomerix

Bronx, New York, United States

Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.

BiotechnologyEdiscoveryMedical
Series AApr 23, 2012
Amount Raised: $2,000,000
Enanta Pharmaceuticals

Watertown, Massachusetts, United States

Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.

BiotechnologyHealth CarePharmaceutical
Series UnknownJan 14, 2004
Amount Raised: $12,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator